Answer
The most common adverse reactions to ustekinumab were nasopharyngitis and headache, occurring in more than 5% during controlled periods of adult psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis studies.
Sources for this answer
- STELARA 130 mg concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.8 Undesirable effects · Version 25Document updated
Sources checked